Axa’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-258,812
| Closed | -$8.61M | – | 1387 |
|
|
2020
Q2 | $8.61M | Sell |
258,812
-25,727
| -9% | -$856K | 0.03% | 470 |
|
|
2020
Q1 | $7.74M | Sell |
284,539
-58,679
| -17% | -$1.6M | 0.04% | 420 |
|
|
2019
Q4 | $6.77M | Buy |
+343,218
| New | +$6.77M | 0.03% | 540 |
|
|
2019
Q1 | – | Sell |
-62,500
| Closed | -$690K | – | 1418 |
|
|
2018
Q4 | $690K | Buy |
+62,500
| New | +$690K | ﹤0.01% | 1032 |
|
|
2018
Q1 | – | Sell |
-75,400
| Closed | -$1.05M | – | 1443 |
|
|
2017
Q4 | $1.05M | Buy |
75,400
+40,300
| +115% | +$562K | ﹤0.01% | 994 |
|
|
2017
Q3 | $649K | Buy |
+35,100
| New | +$649K | ﹤0.01% | 1056 |
|
|
2017
Q2 | – | Sell |
-36,200
| Closed | -$483K | – | 1330 |
|
|
2017
Q1 | $483K | Sell |
36,200
-15,490
| -30% | -$207K | ﹤0.01% | 1081 |
|
|
2016
Q4 | $778K | Sell |
51,690
-90,991
| -64% | -$1.37M | ﹤0.01% | 954 |
|
|
2016
Q3 | $1.67M | Buy |
+142,681
| New | +$1.67M | 0.01% | 803 |
|
|
2016
Q2 | – | Sell |
-67,900
| Closed | -$627K | – | 1435 |
|
|
2016
Q1 | $627K | Buy |
+67,900
| New | +$627K | ﹤0.01% | 953 |
|
|
2015
Q1 | – | Sell |
-241,635
| Closed | -$2.91M | – | 1508 |
|
|
2014
Q4 | $2.91M | Buy |
241,635
+38,088
| +19% | +$459K | 0.01% | 700 |
|
|
2014
Q3 | $2.31M | Sell |
203,547
-199,208
| -49% | -$2.26M | 0.01% | 712 |
|
|
2014
Q2 | $4.87M | Sell |
402,755
-24,560
| -6% | -$297K | 0.02% | 548 |
|
|
2014
Q1 | $4.98M | Buy |
427,315
+29,879
| +8% | +$348K | 0.02% | 521 |
|
|
2013
Q4 | $7.03M | Buy |
397,436
+13,253
| +3% | +$234K | 0.03% | 450 |
|
|
2013
Q3 | $5.53M | Buy |
384,183
+28,937
| +8% | +$416K | 0.03% | 498 |
|
|
2013
Q2 | $5.35M | Buy |
+355,246
| New | +$5.35M | 0.03% | 472 |
|